Pegargiminase Recruiting Phase 3 Trials for Advanced Hepatocellular Carcinoma (HCC) / Hepatocellular Carcinoma Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT05317819Study of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular Carcinoma